MedTrace Logo

Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin

NCT01558570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-09-26

No results posted yet for this study

Summary

The purpose of this protocol is to collect serum zonulin levels in people with schizophrenia. This one time visit will collect zonulin levels, antibodies to gliadin (tissue transglutaminase and antigliadin antibodies) and other information that may relate to increased intracellular tight junction permeability as it related to the immune and stress system and the immune association with kynurenic acid pathway 50. Data will be collected for use in future grant applications and published reports.

Conditions

Interventions

PROCEDURE

Blood Draw

One time blood draw

Sponsors & Collaborators

  • University of Maryland, College Park

    collaborator OTHER

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Deanna L. Kelly, Pharm.D., BCPP · University of Maryland, College Park

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01558570 on ClinicalTrials.gov